Velneperit（肥満治療薬）：市場予測及び分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 14
3.1.1 Etiology 14
3.1.2 Pathophysiology 15
3.1.3 Prognosis 15
3.1.4 Quality of Life 16
3.2 Symptoms 16
4 Disease Management 17
4.1 Treatment Overview 17
5 Competitive Assessment 23
5.1 Overview 23
5.2 Strategic Competitor Assessment 27
6 Opportunity and Unmet Need 29
6.1 Overview 29
6.2 A Drug with Greater Than 10% Average Weight Loss 30
6.2.1 Unmet Need 30
6.2.2 Gap Analysis 31
6.2.3 Opportunity 32
6.3 A Drug with Increased Safety and Tolerability 32
6.3.1 Unmet Need 32
6.3.2 Gap Analysis 33
6.3.3 Opportunity 33
6.4 Reimbursement by Private and Public Payers 33
6.4.1 Unmet Need 33
6.4.2 Gap Analysis 35
6.4.3 Opportunity 35
6.5 Increased Physician Education 35
6.5.1 Unmet Need 35
6.5.2 Gap Analysis 36
6.5.3 Opportunity 36
6.6 Increased Drug-Treatment Rate 37
6.6.1 Unmet Need 37
6.6.2 Gap Analysis 37
6.6.3 Opportunity 38
6.7 Improved Guidelines 38
6.7.1 Unmet Need 38
6.7.2 Gap Analysis 39
6.7.3 Opportunity 39
6.8 Improved Approach to Diagnosis 39
6.8.1 Unmet Need 39
6.8.2 Gap Analysis 40
6.8.3 Opportunity 40
7 Pipeline Assessment 41
7.1 Overview 41
7.2 Promising Drugs in Clinical Development 44
8 Velneperit 47
8.1 Overview 47
8.2 Efficacy 48
8.3 Safety 49
8.4 Dosing and Formulation 49
8.5 Potential Clinical Positioning 49
8.6 Potential Commercial Positioning 50
8.7 Pricing and Reimbursement 50
8.8 SWOT Analysis 50
8.9 Forecast 51
9 Appendix 52
9.1 Bibliography 52
9.2 Abbreviations 57
9.3 Research Methodology 58
9.4 Forecasting Methodology 58
9.4.1 Percent Drug-Treated Obesity Patients 59
9.4.2 Key Launch Dates 59
9.4.3 Individual Drug Assumptions 60
9.4.4 Generic Erosion 60
9.5 Physicians, Specialists, and Payers Included in This Study 61
9.6 About the Authors 64
9.6.1 Analysts 64
9.6.2 Therapy Director – CVMD and Infectious Disease 65
9.6.3 Director – Medical Devices 65
9.6.4 Global Head of Healthcare 66
9.7 About GlobalData 67
9.8 Disclaimer 67